Growth Metrics

Bioventus (BVS) Gross Profit Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 5.02%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 8.10%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 4.54%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 15.44%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 9.03%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.15%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 17.49%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 1.49%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 8.46%
10 Bioventus 535.01 Mn 544.52 Mn 90.77 Mn 7.08%

Historic Data

Download Data 🔒
DateValue
Mar 28, 2026 7.08%
Dec 31, 2025 13.61%
Sep 27, 2025 3.69%
Jun 28, 2025 1.84%
Mar 29, 2025 3.14%
Dec 31, 2024 5.36%
Sep 28, 2024 5.77%
Jun 29, 2024 10.74%
Mar 30, 2024 14.06%
Dec 31, 2023 5.51%
Sep 30, 2023 8.07%
Jul 1, 2023 30.23%
Apr 1, 2023 8.90%